Expanded eligibility for advanced ischemic stroke therapies and the first detailed recommendations pediatric stroke care are ...

This “long overdue” update expands the pools of patients eligible for thrombolysis and thrombectomy, and tackles pediatric ...

AIM: The “2026 Guideline for the Early Management of Patients With AIS” replaces the “2018 Guidelines for the Early Management of Patients With AIS” and the 2019 update to reflect recent advances in ...

Having had a stroke caused by blocked blood vessels (ischemic stroke) more than doubled an expectant mother's odds of having ...

Expanded eligibility for advanced stroke therapies and new recommendations for diagnosing and treating stroke in children and ...

Having had a stroke caused by blocked blood vessels (ischemic stroke) more than doubled an expectant mother's odds of having ...

The approval of this accelerated pathway not only demonstrates the FDA’s full recognition of the quality, safety, and efficacy of the Phase 1 clinical data of hNPC01 in China, but also will ...

Early dual antiplatelet therapy shows superior efficacy in reducing stroke recurrence compared with aspirin monotherapy.

A massive report on the world’s health highlights the impact cardiovascular disease continues to have in all regions of the globe, with ischemic heart disease accounting for 10 million deaths and ...

Ischemic heart disease is expected to become the leading cause of death worldwide by the year 2020 1 and is currently the main cause of acute myocardial infarction (AMI). After the acute thrombotic ...

Introduction: Atrial fibrillation (AF) is a major risk factor for ischemic stroke (IS). Its diagnosis can be challenging, ...